3Nakagawa S,Kojima M,Takada H,et al.Short2duration bladder in stillation therapy with pirarubicin for superficial bladder tumor basedon pharmacodynamic study[J].Gan To Kagaku Ryoho,1992,19:1873-1877.
4Nakagawa S,Kojima M,Nakao M,et al.Flurescence microscopic study on absorption of adriamycin through the rat bladder epithelium[J].Tohoku Exp Med,1987,153:227-232.
5Lum BL,Torti FM.Adjuvant intravesical pharmacology for superficial bladder cancer.J Natl Cancer Inst,1991,83(10):682-694.
6Tolley DA,Hargreave TB,Smith PH,et al.Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer:interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party).Br Med J,1988,296(6639):1759-1761.
7Melekos MD,Dauaher H,Fokaefs E,et al.Intravesical instillations of 4-epi-doxorubicin (epirubicin) in the prophylactictreatment of superficial bladder cancer:results of a controlled prospective study.J Urol,1992,147(2):371-375.
8Oosterlinck W,KurthKH,Schroder F,et al.A prospective European Organization for Research and Treatment of Cancer Genitourinary Group.Randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta,T1 papillary carcinoma of the bladder.J Urol,1993,149(4):749-752.
9Martinez-Pineiro JA,Leon J,Martinez-Pineiro LJr.Bacillus Calmette-Guerin versus doxorubicin versus thiotepa:a randomized prospective study in 202 patients with superficial bladder cancer.J Urol,1990,143(3):502-506.
10Carl L,Bo Johan N,Peter E,et al.A randomized prospective study comparing long-term intravesical instillations of mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma.J Urol,1996,156(2):368-376.
